Herbas VPB

Print
EN | LT
LT - DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
EN - DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 39/00 (2006.01)
A61K 39/00 (2013.01)
C12N 5/00 (2006.01)
A61K2039/505 (2013.01)
C07K 17/14 (2006.01)
A61K 47/6889 (2017.08)
A61P 35/00 (2006.01)
A61K 47/6803 (2017.08)
A61K 47/00 (2006.01)
A61K 47/6849 (2017.08)
A61K 47/6867 (2017.08)
A61K 38/05 (2013.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
European patent
(11) Number of the document 3545969
(13) Kind of document T
(96) European patent application number 19159583.4
Date of filing the European patent application 2010-01-08
(97) Date of publication of the European application 2019-10-02
(45) Date of publication and mention of the grant of the patent 2023-12-13
(46) Date of publication of the claims translation
Priority applications
(30) Number Date Country code
14371309 P 2009-01-09 US
15220509 P 2009-02-12 US
17571909 P 2009-05-05 US
26422209 P 2009-11-24 US
Inventors
(72)
SIEVERS, Eric , US
KENNEDY, Dana , US
IHLE, Nathan , US
SUN, Michael , US
Grantee
(73) Seagen Inc. , 21823 30th Drive S.E., Bothell, WA 98021, US
Title
(54) DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES
  DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES